UNSPSC 51286501: Mupirocin

This classification denotes a topical anti-infective agent with the molecular formula C26H44O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0GX863OA5, chemically known as 8-carboxyoctyl (e)-4-(2s,3r,4r,5s)-5-((2s,3s,4s,5s)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2h-pyran-2-yl)-3-methylcrotonat but more generally known as mupirocin, which bears US NIH Compound Identifier 446596.

UNSPSC 51286501 Mupirocin is a Commodity code that covers pharmaceutical products for state and local health and emergency response procurement. Recent state and local solicitations under this code reveal minimal activity specifically targeting mupirocin; instead, the opportunities posted show demand for a broader class of pharmaceutical supplies and emergency medical products, including antibiotics (doxycycline and ciprofloxacin), naloxone, and drug deactivation systems. State agencies, county health departments, and special-purpose health authorities are the primary issuing bodies, typically sourcing through cooperative purchasing agreements, piggyback contracts, and invitation for bid (IFB) processes. Supply is often managed through regional health consortiums and procurement vehicles that allow multiple jurisdictions to aggregate demand and access negotiated pricing.

Activity under this code spans Florida and Illinois, with procurement concentrated among county-level health authorities and state departments of public health. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for antibiotic tablets totaling $2,999,999.11 over a three-year term with renewal options. Seminole County, Florida issued an IFB on June 30, 2026, for naloxone and drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually), with quarterly deliveries to the Seminole County Community Health Building and delivery costs included in vendor proposals. Neither recent opportunity explicitly targeted mupirocin as a line item; the code's practical activity reflects demand for emergency pharmaceutical supplies and over-the-counter medical products sourced through established health procurement channels rather than mupirocin-specific solicitations.